These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1464 related articles for article (PubMed ID: 24500240)
41. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles. Essa S; Rabanel JM; Hildgen P Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727 [TBL] [Abstract][Full Text] [Related]
42. Tumor-Microenvironment Relaxivity-Changeable Gd-Loaded Poly(L-lysine)/Carboxymethyl Chitosan Nanoparticles as Cancer-Recognizable Magnetic Resonance Imaging Contrast Agents. Jiang D; Zhang X; Yu D; Xiao Y; Wang T; Su Z; Liu Y; Zhang N J Biomed Nanotechnol; 2017 Mar; 13(3):243-54. PubMed ID: 29381026 [TBL] [Abstract][Full Text] [Related]
43. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity. Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239 [TBL] [Abstract][Full Text] [Related]
44. pH-responsive polymeric micelles based on poly(2-ethyl-2-oxazoline)-poly(D,L-lactide) for tumor-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Zhao Y; Zhou Y; Wang D; Gao Y; Li J; Ma S; Zhao L; Zhang C; Liu Y; Li X Acta Biomater; 2015 Apr; 17():182-92. PubMed ID: 25612838 [TBL] [Abstract][Full Text] [Related]
45. pH-sensitive nanoparticles of poly(L-histidine)-poly(lactide-co-glycolide)-tocopheryl polyethylene glycol succinate for anti-tumor drug delivery. Li Z; Qiu L; Chen Q; Hao T; Qiao M; Zhao H; Zhang J; Hu H; Zhao X; Chen D; Mei L Acta Biomater; 2015 Jan; 11():137-50. PubMed ID: 25242647 [TBL] [Abstract][Full Text] [Related]
46. Ionically fixed polymeric nanoparticles as a novel drug carrier. Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262 [TBL] [Abstract][Full Text] [Related]
47. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles. Zhao ZB; Long J; Zhao YY; Yang JB; Jiang W; Liu QZ; Yan K; Li L; Wang YC; Lian ZX Biomater Sci; 2018 Mar; 6(4):893-900. PubMed ID: 29512660 [TBL] [Abstract][Full Text] [Related]
48. Quercetin-loaded poly (lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for the targeted treatment of liver cancer. Guan X; Gao M; Xu H; Zhang C; Liu H; Lv L; Deng S; Gao D; Tian Y Drug Deliv; 2016 Nov; 23(9):3307-3318. PubMed ID: 27067032 [TBL] [Abstract][Full Text] [Related]
49. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
50. Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of Sorafenib. Khan MA; Ali S; Venkatraman SS; Sohail MF; Ovais M; Raza A Int J Pharm; 2018 May; 542(1-2):196-204. PubMed ID: 29551745 [TBL] [Abstract][Full Text] [Related]
51. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release. Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984 [TBL] [Abstract][Full Text] [Related]
52. A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer. Huang H; Li Y; Li C; Wang Y; Sun Y; Wang J Macromol Biosci; 2013 Oct; 13(10):1358-68. PubMed ID: 23852809 [TBL] [Abstract][Full Text] [Related]
53. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. Zhao R; Li T; Zheng G; Jiang K; Fan L; Shao J Biomaterials; 2017 Oct; 143():1-16. PubMed ID: 28755539 [TBL] [Abstract][Full Text] [Related]
54. Polymeric micelles with citraconic amide as pH-sensitive bond in backbone for anticancer drug delivery. Cao J; Su T; Zhang L; Liu R; Wang G; He B; Gu Z Int J Pharm; 2014 Aug; 471(1-2):28-36. PubMed ID: 24836667 [TBL] [Abstract][Full Text] [Related]
55. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Shenoy D; Little S; Langer R; Amiji M Mol Pharm; 2005; 2(5):357-66. PubMed ID: 16196488 [TBL] [Abstract][Full Text] [Related]
56. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin. Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101 [TBL] [Abstract][Full Text] [Related]
57. Theranostic vesicles based on bovine serum albumin and poly(ethylene glycol)-block-poly(L-lactic-co-glycolic acid) for magnetic resonance imaging and anticancer drug delivery. Liu Q; Zhu H; Qin J; Dong H; Du J Biomacromolecules; 2014 May; 15(5):1586-92. PubMed ID: 24690007 [TBL] [Abstract][Full Text] [Related]
58. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
59. Intracellularly Degradable, Self-Assembled Amphiphilic Block Copolycurcumin Nanoparticles for Efficient In Vivo Cancer Chemotherapy. Lv L; Guo Y; Shen Y; Liu J; Zhang W; Zhou D; Guo S Adv Healthc Mater; 2015 Jul; 4(10):1496-501, 1423. PubMed ID: 26033838 [TBL] [Abstract][Full Text] [Related]
60. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging. Xie P; Du P; Li J; Liu P Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]